Tokyo, Japan
NCT Number: NCT01937663
A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation
The purpose of this study is to evaluate the efficacy and safety of tapered KWA-0711 dose in chronic constipation patients.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Primary location
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- The patients who experienced fewer than three spontaneous bowel movements per week for more than 6 months prior to the enrollment.
- The patients who experienced one or more of the following signs or symptoms during more than 25% of bowel movements for more than 6 months: straining, lumpy or hard stools, and a sensation of incomplete evacuation
Exclusion criteria
- Patients who have secondary constipation caused by systemic disorder.
- Patients who have organic constipation.
- Patients who received intestinal resection.
Treatment and study plan
KWA-0711
DrugPrimary outcomes
-
Improvement of signs and symptoms associated with constipation
Time frame: 4 weeks
- Frequency of Spontaneous Bowel Movements
- Bowel Movement Timing
- Stool Consistency
- Abdominal Assessment
- QOL Assessment
Sponsors and collaborators
Lead sponsor
Kissei Pharmaceutical Co., Ltd.
Industry
Registry information
Important dates
- Primary completion
- 2014
- First posted
- Sep 9, 2013
- Registry last updated
- Nov 13, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation
NCT01938196
Chronic Constipation, Constipation
Tokyo, Japan
View Trial DetailsEvaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
NCT00391820
Bronchial Diseases, Bronchiolitis
Houston, Texas, United States
View Trial DetailsEffect to Linaclotide on Colonic Motility
NCT06989268
Chronic Constipation, Constipation
View Trial DetailsDrinking Effect of Electrolyzed Alkaline Reduced Water on Functional Constipation
NCT05734859
Chronic Constipation, Constipation
Wŏnju, Ganwon-do, South Korea
View Trial Details